Meeting
2023 ASCO Quality Care Symposium
Innovative biomarker testing initiative in a community oncology setting.
Authors
Lorraine Brisbin
Texas Oncology PA, The Hills, TX
Lorraine Brisbin, Brittnie Berry, Trey Schuchart, Frederico Ruiz, Ayda Mirsalehi, Neal Dave, R. Steven Paulson, Sucharu Prakash, Shikha Prakash
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Survivorship
Sub Track
Application of Quality Improvement Tools
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 385)
DOI
10.1200/OP.2023.19.11_suppl.385
Abstract #
385
Poster Bd #
G13
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Caveat emptor: A descriptive analysis of guideline-recommended biomarker inclusion in targeted NGS panels for metastatic non-small cell lung cancer (mNSCLC).
First Author: John Leonard Fox
Poster
2022 ASCO Annual Meeting
Multiomics analysis of pediatric solid tumors within the INFORM precision oncology study: From functional drug profiling to biomarker identification.
First Author: Dina ElHarouni
First Author: Davendra Sohal
Poster
2024 ASCO Annual Meeting
Genomic landscape and therapeutic implications in advanced solid cancers: KOSMOS-II (KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors, KCSG AL-22-09).
First Author: Heejung Chae